Prelude Therapeutics Inc (PRLD) stock
PRLDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 8/3055% above fair value
$3.32−0.09 (-2.64%)
Close on Nov 17, 2026Market cap $264.95MP/E –Yield –
Prelude Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Prelude Therapeutics's market cap was $318.23M on Nov 11, 2026, against $127.67M a year earlier. Over the last 5 years it ranged from $57.54M to $471.45M, with a median of $232.66M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $318.23M | +44.4% |
| 2025 | Dec 31, 2025 | $220.39M | +132.8% |
| 2024 | Dec 31, 2024 | $94.65M | -59.6% |
| 2023 | Dec 29, 2023 | $234.11M | -17.7% |
| 2022 | Dec 30, 2022 | $284.59M | +96.2% |
| 2021 | Jan 29, 2021 | $145.04M | -9.2% |
| 2020 | Dec 31, 2020 | $159.77M | – |
See a number that looks wrong?